Lyell Immunopharma Inc (LYEL)
2.36
-0.04
(-1.67%)
USD |
NASDAQ |
May 03, 16:00
2.36
0.00 (0.00%)
After-Hours: 20:00
Lyell Immunopharma 1 Year Total Returns (Daily): 1.72% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.72% |
| May 02, 2024 | 15.94% |
| May 01, 2024 | 8.88% |
| April 30, 2024 | 6.90% |
| April 29, 2024 | 10.84% |
| April 26, 2024 | 14.81% |
| April 25, 2024 | 13.99% |
| April 24, 2024 | 12.75% |
| April 23, 2024 | 5.63% |
| April 22, 2024 | 4.33% |
| April 19, 2024 | -8.98% |
| April 18, 2024 | -2.10% |
| April 17, 2024 | -6.30% |
| April 16, 2024 | 2.12% |
| April 15, 2024 | 1.69% |
| April 12, 2024 | 17.12% |
| April 11, 2024 | -5.34% |
| April 10, 2024 | -8.24% |
| April 09, 2024 | -9.68% |
| April 08, 2024 | -21.51% |
| April 05, 2024 | -18.68% |
| April 04, 2024 | -19.92% |
| April 03, 2024 | -20.46% |
| April 02, 2024 | -11.86% |
| April 01, 2024 | -7.63% |
| Date | Value |
|---|---|
| March 28, 2024 | 0.45% |
| March 27, 2024 | -6.85% |
| March 26, 2024 | -3.48% |
| March 25, 2024 | -4.48% |
| March 22, 2024 | -6.80% |
| March 21, 2024 | -7.27% |
| March 20, 2024 | -6.22% |
| March 19, 2024 | -6.57% |
| March 18, 2024 | -2.35% |
| March 15, 2024 | -1.37% |
| March 14, 2024 | -5.96% |
| March 13, 2024 | 5.38% |
| March 12, 2024 | 9.55% |
| March 11, 2024 | 17.09% |
| March 08, 2024 | 21.84% |
| March 07, 2024 | 20.57% |
| March 06, 2024 | 25.12% |
| March 05, 2024 | 13.06% |
| March 04, 2024 | 17.34% |
| March 01, 2024 | 27.92% |
| February 29, 2024 | 35.81% |
| February 28, 2024 | 32.09% |
| February 27, 2024 | 30.14% |
| February 26, 2024 | 23.00% |
| February 23, 2024 | 3.46% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-82.54%
Minimum
Oct 04 2023
35.81%
Maximum
Feb 29 2024
-47.79%
Average
-53.27%
Median
1 Year Total Returns (Daily) Benchmarks
| GlycoMimetics Inc | 34.56% |
| Candel Therapeutics Inc | 467.3% |
| Eliem Therapeutics Inc | 196.9% |
| Entrada Therapeutics Inc | 7.52% |
| NovaBay Pharmaceuticals Inc | -90.79% |